Product Information
2-(Pyridin-3-yl)propanoic acid is a quinoline derivative that has been shown to be safe and effective in clinical trials. It is being tested for the treatment of type 2 diabetes, obesity, and metabolic syndrome. The oral administration of this drug inhibits the activity of dipeptidyl peptidase-4 (DPP-4), which is an enzyme involved in the degradation of insulin. This inhibition leads to increased levels of insulin in the blood and improved glucose tolerance. 2-(Pyridin-3-yl)propanoic acid interacts with other drugs through competitive inhibition at their binding sites on enzymes. Optimization experiments have shown that it can interact with pyridine compounds, which are found in many drugs including acetaminophen and caffeine.
Chemical properties
Technical inquiry about: 3D-QDA00562 2-(Pyridin-3-yl)propanoic acid
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
